Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Quadro Iliac Plane Block for Pain Control After Kidney Stone Surgery

Official title: Comparison of the Effects of Ultrasound-Guided Quadro-İliac Plane Block on Postoperative Pain Level and Analgesia Requirement in Patients Undergoing Percutaneous Nephrolithotomy

Run by Cumhuriyet University · NCT07203859 · Data updated 2026-11-12

This study tests whether a regional block called QİPB can reduce pain after percutaneous nephrolithotomy in adults.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorCumhuriyet University
Academic / other
Locations1 site (Sivas, Sivas)
StatusRecruiting
StartedSeptember 25, 2025
Main results expectedSeptember 1, 2026
Study endsOctober 2026
Registry record updatedJune 3, 2026
Trial IDNCT07203859 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 undergoing percutaneous nephrolithotomy under general anesthesia, classified ASA I–III, who consent to participate.

Probably not a fit

Patients with contraindications to regional anesthesia, active infection at the block site, coagulopathy, or those unable to report pain scores may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates the effectiveness of the quadro iliac plane block (QİPB) as a regional anesthesia technique for postoperative analgesia following percutaneous nephrolithotomy. Adult patients (ASA I–III) undergoing the procedure under general anesthesia are included, with exclusions for coagulopathy, infection at the block site, anticoagulant use, allergies to study drugs, unstable vitals, and inability to cooperate with pain assessments. The aim is to determine the block’s analgesic impact and delineate the skin regions anesthetized by QİPB. Safety and feasibility outcomes are likely collected alongside pain scores and opioid use, if applicable.

Why it matters

Potential benefit: If successful, QİPB could provide effective postoperative pain relief and possibly reduce opioid requirements after nephrolithotomy.

How similar studies have gone: Prior regional anesthesia approaches have shown analgesic benefits in similar surgical contexts, but specific evidence for QİPB in this procedure is limited and this study explores its feasibility and effectiveness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients over 18 years of age who underwent percutaneous nephrolithotomy under general anesthesia and were I-II-III according to the American Society of Anesthesiologists (ASA) risk classification were included in the study.

Exclusion Criteria:

* patients who did not give consent,
* patients with coagulopathy,
* patients with signs of infection at the block application site,
* patients using anticoagulants,
* patients with known allergies to any of the study drugs,
* patients with unstable hemodynamics,
* patients who could not cooperate during postoperative pain assessment
* patients who wanted to withdraw from the study,
* patients with alcohol and drug addiction,
* patients with musculoskeletal abnormalities

Where it's running

  • Sivas Cumhuriyet University
    Sivas, Sivas, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Oğuz Gündoğdu — Sivas Cumhuriyet University School of Medicine, Anesthesiology and Reanimation
  • Study coordinator: Oğuz Gündoğdu
  • Email: droguzgundogdu@gmail.com
  • Phone: +905545945469

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.